| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/18/1999 | WO1998051348A3 Sustained-release delayed gels |
| 02/18/1999 | WO1998027972A3 Anti-amyloidogenic agents |
| 02/18/1999 | CA2301068A1 Composition comprising propolis and at least an essential oil |
| 02/18/1999 | CA2299555A1 Complex chemical compound, synthesis and various applications of said compound |
| 02/18/1999 | CA2299393A1 Injectable biodegradable block copolymer gels for use in drug delivery |
| 02/18/1999 | CA2299368A1 Conjugates targeted to the interleukin-2 receptor |
| 02/18/1999 | CA2299336A1 Hemostatic tissue sealants |
| 02/18/1999 | CA2299298A1 Compositions for nasal administration |
| 02/18/1999 | CA2298932A1 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 02/18/1999 | CA2268030A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions |
| 02/17/1999 | EP0896821A1 A novel pharmaceutical composition for inhalation containing CR 2039 (andolast) |
| 02/17/1999 | EP0896820A1 Ophthalmic composition comprising naloxone and at least one polyhydric alcohol |
| 02/17/1999 | EP0896818A1 Improved rapidly disintegratable multiparticulate tablet |
| 02/17/1999 | EP0896815A1 Suspension of sparingly water-soluble acidic drug |
| 02/17/1999 | EP0896626A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 02/17/1999 | EP0896603A1 Polymer powders redispersible in aqueous solution |
| 02/17/1999 | EP0896541A1 Silver-based pharmaceutical compositions |
| 02/17/1999 | EP0896534A1 Injection formulations of avermectins and milbemycins based on castor oil |
| 02/17/1999 | EP0896529A1 Estradiol and progesterone-based medicament |
| 02/17/1999 | EP0896528A2 Polyol composition |
| 02/17/1999 | EP0896527A1 Pharmaceutical compositions for the sustained release of insoluble active principles |
| 02/17/1999 | EP0784506B1 Method of coating particles |
| 02/17/1999 | EP0633774B1 Topical administration of toremifene and its metabolites |
| 02/17/1999 | CN1208350A High-content famciclovir tablets |
| 02/17/1999 | CN1208345A Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 02/17/1999 | CN1207946A Thioether conjugates |
| 02/17/1999 | CN1207898A Simethicone/anhydrous calcium phosphate compositions |
| 02/17/1999 | CN1207896A Solid pharmaceutical dispersions with enhanced bioavailability |
| 02/17/1999 | CN1207895A Clarithromycin capsule |
| 02/17/1999 | CN1042134C Lipophilic surfactant-yolk phospholipid and its producing process |
| 02/16/1999 | US5872232 2'-O-modified oligonucleotides |
| 02/16/1999 | US5872223 Immunoconjugates comprising tyrosine kinase inhibitors |
| 02/16/1999 | US5872222 Conjugate comprises nonimmunogenic polymer coupled with a plurality of binding molecules, each being specific for an antigen on a t cell, and binding molecule lacking an fc portion |
| 02/16/1999 | US5872149 Alk(en)yldicarboxylic acid bisesters, their use, and processes for their preparation |
| 02/16/1999 | US5872129 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents |
| 02/16/1999 | US5871802 Animal feed pelleting process and animal feed pellets produced therefrom |
| 02/16/1999 | US5871775 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance |
| 02/16/1999 | US5871771 Micronized biodegradable particles, process for preparing them and use thereof |
| 02/16/1999 | US5871769 Using magnesium gluconate alone or in combination with antioxidants selected from vitamin e, selenium, glutathione, isopropyl glutathionate and n-acetylcysteine; prevention of oxygen free radical and lipid peroxidation production |
| 02/16/1999 | US5871767 Implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete biologically active material dispersed in biocompatible matrix, surrounded by biocompatible external jacket |
| 02/16/1999 | US5871759 Cholesterol ester clathrate, water-holding composition, hydrous compositions, cosmetics containing the same, and processes for the preparation thereof |
| 02/16/1999 | US5871757 Adding a combination of essential oils |
| 02/16/1999 | US5871753 A compound comprising two or more multimerized ligands each independently selected from the group consisting of fk506, fk520 and cyclosporin, or macrocyclic derivatives thereof. |
| 02/16/1999 | US5871747 Antigen-carrying microparticles and their use in the indication of humoral or cellular responses |
| 02/16/1999 | US5871746 For immunizing against pathogenic agents such as viruses orparasites; one or more chains derived from fatty acids or modified steroid groups |
| 02/16/1999 | US5871737 Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein |
| 02/16/1999 | US5871736 Liquid immunoglobulin formulations |
| 02/16/1999 | US5871722 Ionic beads useful for controlled release and adsorption |
| 02/16/1999 | US5871714 Compositions for controlling bacterial colonization |
| 02/16/1999 | US5871710 Graft co-polymer adducts of platinum (II) compounds |
| 02/16/1999 | CA2153234C Aqueous drug composition having property of reversible thermosetting gelation |
| 02/16/1999 | CA2152795C Readily available konjac glucomannan sustained release excipient |
| 02/16/1999 | CA2138020C Pharmaceutical composition containing botulinum b complex |
| 02/16/1999 | CA2104733C Urea/lactate topical compositions for dry skin |
| 02/16/1999 | CA2084919C Sustained release tablets |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/11/1999 | WO1999006072A1 Cyclized prodrugs |
| 02/11/1999 | WO1999006071A1 Modified polypeptides with high activity and reduced allergenicity |
| 02/11/1999 | WO1999006070A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006065A1 Aqueous preparation of lactoferrin having improved stability |
| 02/11/1999 | WO1999006055A1 Polynucleotide compositions |
| 02/11/1999 | WO1999006051A1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 02/11/1999 | WO1999006045A1 Controlled release pharmaceutical compositions containing tiagabine |
| 02/11/1999 | WO1999006044A1 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
| 02/11/1999 | WO1999006043A1 Self-emulsifying formulation for lipophilic compounds |
| 02/11/1999 | WO1999006038A1 Fast-acting analgesic |
| 02/11/1999 | WO1999006032A2 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 02/11/1999 | WO1999006029A1 Ascorbic acid-based formulation with improved colour stability |
| 02/11/1999 | WO1999006027A1 Pellet-type formulation intended for treating the intestinal tract |
| 02/11/1999 | WO1999006026A1 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 02/11/1999 | WO1999006024A1 Self-emulsifying formulation for lipophilic compounds |
| 02/11/1999 | WO1999006023A1 Ophthalmic compositions containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006011A2 Shellac-containing cosmetic product |
| 02/11/1999 | WO1998051812A3 Polyhydroxyalkanoates for in vivo applications |
| 02/11/1999 | WO1998047496A3 Polymer-platinum compounds |
| 02/11/1999 | WO1998040104A3 Covalent conjugates of topoisomerase i and topoisomerase ii inhibitors |
| 02/11/1999 | WO1998035703A3 Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents |
| 02/11/1999 | WO1998033528A3 Induction of b cell tolerance |
| 02/11/1999 | WO1998030239A3 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 02/11/1999 | DE19728737C1 Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten A method for the detection and determination of GnRH receptors and the use of GnRH agonists and GnRH-antagonists for the treatment of a tumor originating in the brain and / or nervous system and / or the meninges |
| 02/11/1999 | CA2298624A1 Ascorbic acid-based formulation having improved colour stability |
| 02/11/1999 | CA2298061A1 Polynucleotide compositions |
| 02/11/1999 | CA2297437A1 Modified polypeptides with high activity and reduced allergenicity |
| 02/11/1999 | CA2296394A1 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 02/11/1999 | CA2294032A1 Self-emulsifying formulation for lipophilic compounds |
| 02/11/1999 | CA2294024A1 Shellac-containing cosmetic product |
| 02/10/1999 | EP0895784A1 Medicament composite |
| 02/10/1999 | EP0895782A2 Pharmaceutical compositions of Cilansetron stabilized against racemisation |
| 02/10/1999 | EP0895780A1 Extended release tablets particularly containing pseudoephedrine hydrochloride |
| 02/10/1999 | EP0895777A2 Compositions based on peroxyacids |
| 02/10/1999 | EP0895543A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 02/10/1999 | EP0895474A1 Liquid eye drop composition |
| 02/10/1999 | EP0895473A1 Polysaccharide microspheres for the pulmonary delivery of drugs |
| 02/10/1999 | EP0695193B1 Transdermal active-substance preparation |
| 02/10/1999 | EP0669940B1 Specifically crosslinked hemoglobin with free functionality |
| 02/10/1999 | CN1207749A Process for preparation of porous polyolefin particles |
| 02/10/1999 | CN1207744A Photocured cross-linked-hyaluronic acid gel and method of preparation thereof |
| 02/10/1999 | CN1207687A Pharmaceutical compositions with vitamin D analogues |
| 02/10/1999 | CN1207686A FC 'epsilon'-PE chimeric protein for targeted treatment of allergy responses, method for its production and pharmaceutical compositions contg. same |
| 02/10/1999 | CN1207684A Enzymatic method and compositions for treating intravitreal hemorrhagic blood |